Jonathan Isaac Macy MD

Ophthalmology•Los Angeles, CA

Cataract Related, Glaucoma Related, Refractive Surgery

Macy Eye Center

Join to View Full Profile

8635 W 3rd StSte 360WLos Angeles, CA 90048
Phone+1 310-657-2777
Fax+1 310-657-0356

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1978 - 1981
University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 1976 - 1977
Boston University School of MedicineClass of 1976

Certifications & Licensure

CA State Medical License 1977 - 2026
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

ESGR Patriot Award United States Navy, 2011
Distinguished Alumnus Award USC Department of Ophthalmology, 2008
Senior Honor Award UCLA Department of Ophthalmology, 2008
Magna Cum Laude Boston University, 1972
Phi Beta Kappa Phi Beta Kappa, 1972
Super Doctor SuperDoctors.com
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

Clinical Trials

A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Start of enrollment: 2012 Apr 01
Completed
Cornea Donor Study Start of enrollment: 2000 Jan 10
Completed
Not Applicable
Travoprost 3-Month Safety and Efficacy Study Start of enrollment: 2011 Nov 01
Completed
Phase 3
Zylet vs TobraDex in Blepharokeratoconjunctivitis Start of enrollment: 2007 Jan 01
Completed
Phase 4
A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients Start of enrollment: 1997 Aug 01
Completed
Phase 3
Evaluation of Efficacy and Safety of Vismed Gel Multi 0.3% Versus Vismed Multi 0.18% on Treatment of Ocular Dryness Start of enrollment: 2018 Sep 01
Unknown status
Not Applicable
An Open Label Comparing the Short Term Efficacy of Lacrisert Start of enrollment: 2016 Nov 01
Unknown status
Phase 4
Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery Start of enrollment: 2014 Sep 01
Completed
Phase 3
Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma Start of enrollment: 2015 Sep 01
Completed
Phase 3
Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% Start of enrollment: 2011 Feb 01
Completed
Phase 3
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis Start of enrollment: 2012 May 01
Completed
Phase 2
Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis Start of enrollment: 2013 Feb 01
Terminated
Phase 3
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease Start of enrollment: 2014 Jun 01
Completed
Phase 2
Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion Start of enrollment: 2017 Jul 31
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

41 citations
Determinants of Outcomes of Adenoviral Keratoconjunctivitis.
Cecilia S Lee, Aaron Y. Lee, Lakshmi Akileswaran, David W. Stroman, Kathryn Najafi-Tagol
Ophthalmology. 2018-03-27
109 citations
Factors Associated With Corneal Graft Survival in the Cornea Donor Study
Alan Sugar, Robin L. Gal, Craig Kollman, Dan Raghinaru, Mariya Dontchev
JAMA Ophthalmology. 2015-03-01
35 citations
Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry.
Jodi Luchs, Donald S Nelinson, Jonathan I Macy
Cornea. 2010-12-01

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow

Other Languages

Spanish